In more severe cases, the condition can also cause angioedema, a swelling of the tissues beneath the skin. This is a deeper swelling than hives and can be more painful. Both urticaria and ...

There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and ...

The following is a summary of “Dupilumab Improves Dermatology-Specific Quality of Life in Patients with Chronic Spontaneous ...

A 43-year-old woman presented with 6 months of recurrent bilateral eye pain and redness alongside spontaneous urticaria.She ...

Chronic urticaria (CU) is a dermatological condition characterized by recurrent wheals (hives), angioedema (deep tissue swelling), or both, persisting for over 6 weeks. 1 Unlike acute urticaria ...

Key presentations on chronic spontaneous urticaria (CSU) at the American Academy of Dermatology 2025 include late-breaking data on the anti-c-Kit antibody briquilimab and positive results for ...

Angioedema and hives share some of the same underlying causes, although symptoms often differ. A case of hives (urticaria), ...

Urticaria, commonly known as hives, is a skin condition that manifests as itchy welts or raised patches on the skin. These welts can vary in size and often change shape or location, making the ...

The US Food and Drug Administration (FDA) has approved dupilumab for the treatment of chronic spontaneous urticaria (CSU) in patients aged 12 years and older who “remain symptomatic despite H1 ...

Dupilumab was approved for treatment of chronic spontaneous urticaria in patients aged 12 years and older. Several studies reported reduced itch severity and urticaria activity with dupilumab.